Although the findings confirm the association of hyperglycemia, HIF-1a, and CCRT efficacy in rectal cancer patients, the population of this study is too small and the number of cases received needs to increase to more accurately confirm the association between the factors. The gene discussed is HIF1A; the disease is rectal cancer.